Cover Image
Market Research Report

Europe Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro

Published by iData Research Inc. Product code 524557
Published Content info 460 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro
Published: June 1, 2017 Content info: 460 Pages
Description

The full report suite on the U.S.European market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix and synthetic bone graft market. The report also includes hyaluronic acid viscosupplementation, orthopedic growth factors, orthopedic cell therapy, orthopedic cartilage repair and spinal machined bone allograft markets.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Lack of reimbursements can limit the European orthopedic biomaterials market. When a product is reimbursed, it is more readily adopted. For instance, in the hyaluronic acid market, most products are classified as medical devices and thus are not eligible for reimbursement. Only a few premium products under the umbrella of pharmaceuticals are reimbursed by the government or healthcare organizations. In addition to not being as well received as reimbursed products, the lack of reimbursement drives pricing down in an effort to make them more affordable. This price deterioration will have a negative impact on the market, as it may not be economically feasible for certain competitors to penetrate a market with low ASPs.

Unlike donated material, synthetic bone graft materials do not carry the risk of disease transmission, nor will they generate an immunogenic response in the recipient. As with allograft, the use of synthetic materials avoids the need for a second bone harvesting procedure. These products have been steadily reducing the amount of autograft bone that doctors have been using. Popularity of synthetics due to the affordability and easy accessibility, synthetic products are becoming the preferred products over allografts, DBMs and autografts. A wide range of synthetic products can offer flexibility and variety for different groups of patients. People in general are becoming more knowledgeable and accepting of synthetic products.

Table of Contents
Product Code: iDATA_EUOB17_MP

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Osteology and Musculoskeletal System
  • 2.2. DISEASE PATHOLOGY AND DISORDERS
    • 2.2.1. General Diagnostic
    • 2.2.2. Osteoporosis
    • 2.2.3. Osteoarthritis
    • 2.2.4. Indication for Bone Graft Procedure
    • 2.2.5. Indication for Cartilage Repair
    • 2.2.6. Degenerative Disc Disease
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. General Statistics

COUNTRY PROFILES

  • 3.1. INTRODUCTION
    • 3.1.1. Population
    • 3.1.2. GDP Per Capita
    • 3.1.3. Price Index
  • 3.2. GERMANY
  • 3.3. FRANCE
  • 3.4. UNITED KINGDOM
  • 3.5. ITALY
  • 3.6. SPAIN
  • 3.7. BENELUX
  • 3.8. SCANDINAVIA
  • 3.9. AUSTRIA
  • 3.10. SWITZERLAND
  • 3.11. PORTUGAL

PROCEDURE NUMBERS

  • 4.1. PROCEDURE DEFINITIONS
  • 4.2. BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
    • 4.2.1. By Material
    • 4.2.2. By Indication
    • 4.2.3. Units per Procedure by Indication
  • 4.3. GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS
  • 4.4. HYALURONIC ACID TREATMENT NUMBERS BY TYPE
  • 4.5. CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023
  • Chart 1 2: Orthopedic Biomaterials Market Overview, Europe, 2016 & 2023
  • Chart 3 1: Country Profile, Germany, 2016
  • Chart 3 2: Country Profile, France, 2016
  • Chart 3 3: Country Profile, United Kingdom, 2016
  • Chart 3 4: Country Profile, Italy, 2016
  • Chart 3 5: Country Profile, Spain, 2016
  • Chart 3 6: Country Profile, Benelux, 2016
  • Chart 3 7: Country Profile, Scandinavia, 2016
  • Chart 3 8: Country Profile, Austria, 2016
  • Chart 3 9: Country Profile, Switzerland, 2016
  • Chart 3 10: Country Profile, Portugal, 2016
  • Chart 4 1: Bone Graft Substitute Procedure Numbers by Material, Europe, 2013 - 2023
  • Chart 4 2: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2013 - 2023
  • Chart 4 3: Growth Factor Bone Graft Procedure Numbers, Europe, 2013 - 2023
  • Chart 4 4: Hyaluronic Acid Treatment Numbers by Type, Europe, 2013 - 2023
  • Chart 4 5: Cartilage Repair Procedure Numbers by Type, Europe, 2013 - 2023

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2016
  • Figure 1 2: Companies Researched in this Report, Europe, 2016
  • Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe
  • Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, Europe, 2015 - 2016
  • Figure 1 5: Orthopedic Biomaterials Markets Covered, Europe, 2016 (1 of 2)
  • Figure 1 6: Orthopedic Biomaterials Markets Covered, Europe, 2016 (2 of 2)
  • Figure 1 7: Key Report Updates
  • Figure 1 8: Version History
  • Figure 4 1: Procedures by Country, Bone Graft Substitutes Market, Europe, 2013 - 2023
  • Figure 4 2: Bone Graft Substitute Procedure Numbers by Material, Europe, 2013 - 2023
  • Figure 4 3: Bone Graft Substitute Procedure Numbers by Indication, Europe, 2013 - 2023
  • Figure 4 4: Growth Factor Bone Graft Procedure Numbers, Europe, 2013 - 2023
  • Figure 4 5: Procedures by Country, Growth Factor Market, Europe, 2013 - 2023
  • Figure 4 6: Hyaluronic Acid Treatment Numbers by Type, Europe, 2013 - 2023
  • Figure 4 7: Procedures (Total Injections) by Country, Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023
  • Figure 4 8: Cartilage Repair Procedure Numbers by Type, Europe, 2013 - 2023
  • Figure 4 9: Procedures by Country, Cartilage Repair Market, Europe, 2013 - 2023
  • Figure 6 1: Press Release Summary
Back to Top